Activity of tedizolid (TR-700) against well-characterized methicillin-resistant staphylococcus aureus strains of diverse epidemiological origins

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 6, 2013, Pages 2892-2895

  Thomson, Kenneth S ^a   Goering, Richard V ^a  

^a CREIGHTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CLINDAMYCIN; DAPTOMYCIN; ERYTHROMYCIN; GENTAMICIN; LEVOFLOXACIN; LINEZOLID; OXACILLIN; SULFAMETHOXAZOLE; TEDIZOLID; TIGECYCLINE; TRIMETHOPRIM; VANCOMYCIN;

ARTICLE; BACTERIAL STRAIN; DRUG POTENCY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; DAPTOMYCIN; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE; ORGANOPHOSPHATES; OXAZOLES; STAPHYLOCOCCAL INFECTIONS;

EID: 84877844310     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00274-13     Document Type: Article

References (9)

1. Ratnaraja NV, Hawkey PM. 2008. Current challenges in treating MRSA: What are the options? Expert Rev. Anti Infect. Ther. 6:601-618.
2. Dulon M, Haamann F, Peters C, Schablon A, Nienhaus A. 2011. MRSA prevalence in European healthcare settings: A review. BMC Infect. Dis. 11: 138. doi:10.1186/1471-2334-11-138.
3. Yanagihara K, Kaneko Y, Sawai T, Miyazaki Y, Tsukamoto K, Hirakata Y, Tomono K, Kadota J, Tashiro T, Murata I, Kohno S. 2002. Efficacy of linezolid against methicillin-resistant or vancomycin-insensitive Staphylococcus aureus in a model of hematogenous pulmonary infection. Antimicrob. Agents Chemother. 46:3288-3291.
4. Brown SD, Traczewski MM. 2010. Comparative in vitro antimicrobial activities of torezolid (TR-700), the active moiety of a new oxazolidinone, torezolid phosphate (TR-701), determination of tentative disk diffusion interpretive criteria, and quality control ranges. Antimicrob. Agents Chemother. 54:2063-2069.
5. Rodríguez-Avial I, Culebras E, Betriu C, Morales G, Pena I, Picazo JJ. 2012. In vitro activity of tedizolid (TR-700) against linezolid-resistant staphylococci. J. Antimicrob. Chemother. 67:167-169.
6. Goering RV, Ribot EM, Gerner-Smidt P. 2011. Pulsed-field gel electrophoresis: Laboratory and epidemiologic considerations for interpretation of data. In Persing DH, Tenover FC, Tang YW, Nolte FS, Hayden RT, Belkum AV (ed), Molecular microbiology: Diagnostic principles and practice, 2nd ed. ASM Press, Washington, DC.
7. Enright MC, Day NP, Davies CE, Peacock SJ, Spratt BG. 2000. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J. Clin. Microbiol. 38:1008-1015.
8. Shopsin B, Gomez M, Montgomery SO, Smith DH, Waddington M, Dodge DE, Bost DA, Riehman M, Naidich S, Kreiswirth BN. 1999. Evaluation of protein A gene polymorphic region DNA sequencing for typing of Staphylococcus aureus strains. J. Clin. Microbiol. 37:3556-3563.
9. Clinical and Laboratory Standards Institute. 2011. Performance standards for antimicrobial susceptibility testing; twenty-first informational supplement M100-S21. Clinical and Laboratory Standards Institute, Wayne, PA.